Skip navigation

News & Events

Keep up to date on AgNovos events and related news

Archive - 2020

AgNovos Healthcare participates at virtual congress digital O&U 2020 on October 19th – 23rd

AgNovos Healthcare will participate at the virtual congress digital O&U 2020

AgNovos Healthcare has generated strong interest with the Breakthrough Designation by the FDA and was mentioned in reputable press portals

The recently issued press release on the FDA's "Breakthrough Designation" for AgNovos' newest investigational product, AGN1 Local Osteo-enhancement Procedure (LOEP) Small Volume (SV) Kit, has generated a strong of interest in the industry and has been posted on several reputable press portals.

AgNovos Healthcare Receives Breakthrough Designation for Spine Device

AgNovos Healthcare is pleased to announce that its newest investigational product, AGN1 Local Osteo-enhancement Procedure (LOEP) Small Volume (SV) Kit, has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA).

AgNovos Healthcare at Osteologie Kongress Salzburg in March 2020

AgNovos Healthcare will participate in the “Osteologie Kongress” in Salzburg from March 12th - 14th where we will exhibit the CE-marked OSSURE LOEP kit.

AgNovos Healthcare at WCO in Barcelona from April 2nd – 5th, 2020

AgNovos Healthcare will participate in the WCO in Barcelona from April 2nd – 5th, 2020.

AgNovos Healthcare at 5th Alterstraumatologie Kongress Munich 2020

AgNovos Healthcare will participate in the “Alterstraumatologie Kongress” in Munich from March 19th - 20th where we will exhibit the CE-marked OSSURE LOEP kit.